CynergisTek (CTEK) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of CynergisTek (NYSEAMERICAN:CTEK) from a strong-buy rating to a hold rating in a research report report published on Wednesday.

According to Zacks, “CynergisTek, Inc. provides cyber security and information management consulting in healthcare industry. It specializes in privacy, security, compliance and document management. The company’s service includes risk assessment, technical security, baseline security, information security program assessment, print security, vulnerability, architecture, penetration testing, social engineering and phishing and riskSonar assessment tool. CynergisTek Inc., formerly known as Auxilio, Inc., is headquartered in Mission Viejo, CA. “

Shares of NYSEAMERICAN CTEK opened at $4.77 on Wednesday. CynergisTek has a 1-year low of $3.23 and a 1-year high of $5.45.



CynergisTek (NYSEAMERICAN:CTEK) last announced its earnings results on Wednesday, November 7th. The company reported $0.23 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.09. The firm had revenue of $19.22 million for the quarter, compared to the consensus estimate of $18.65 million.

A number of large investors have recently modified their holdings of CTEK. Csenge Advisory Group acquired a new stake in shares of CynergisTek in the 3rd quarter valued at $62,000. King Luther Capital Management Corp boosted its holdings in shares of CynergisTek by 22.5% in the 2nd quarter. King Luther Capital Management Corp now owns 108,750 shares of the company’s stock valued at $428,000 after purchasing an additional 20,000 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of CynergisTek by 30.2% in the 3rd quarter. Vanguard Group Inc. now owns 98,036 shares of the company’s stock valued at $377,000 after purchasing an additional 22,722 shares in the last quarter. Vanguard Group Inc boosted its holdings in shares of CynergisTek by 30.2% in the 3rd quarter. Vanguard Group Inc now owns 98,036 shares of the company’s stock valued at $377,000 after purchasing an additional 22,722 shares in the last quarter. Finally, Bridgeway Capital Management Inc. boosted its holdings in shares of CynergisTek by 50.5% in the 3rd quarter. Bridgeway Capital Management Inc. now owns 164,000 shares of the company’s stock valued at $631,000 after purchasing an additional 55,000 shares in the last quarter.

About CynergisTek

Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.

Featured Story: What is Compound Annual Growth Rate (CAGR)?

Get a free copy of the Zacks research report on CynergisTek (CTEK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply